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Helminths are credited with being the major selective force driving the evolution of the
so-called “type 2” immune responses in vertebrate animals, with their size and infection
strategies presenting unique challenges to the immune system. Originally, type 2 immune
responses were defined by the presence and activities of the CD4+ T-helper 2 subset pro-
ducing the canonical cytokines IL-4, IL-5, and IL-13. This picture is now being challenged
by the discovery of a more complex pattern of CD4+ T-helper cell subsets that appear
during infection, including Tregs, Th17, Tfh, and more recently, Th22, Th9, and ThGM. In
addition, a clearer view of the mechanisms by which helminths and their products selec-
tively prime the CD4+T-cell subsets is emerging. In this review, we have focused on recent
data concerning the selective priming, differentiation, and functional role of CD4+ T-helper
cell subsets in the context of helminth infection. We argue for a re-evaluation of the original
Th2 paradigm and discuss how the observed plasticity of the T-helper subsets may enable
the parasitized host to achieve an appropriate compromise between elimination, tissue
repair, containment, and pathology.
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INTRODUCTION
Helminth parasites are an extremely successful group of organ-
isms infecting over one billion people, with some able to parasitize
a host for several decades. Helminths are phylogenetically diverse,
with a broad range of migration patterns and life cycles, and are
spread across three phyla: nematodes, trematodes, and cestodes.
Despite their diversity, the mammalian immune response against
these helminths is consistently of the type 2 phenotype character-
ized by IgE antibody production, eosinophilia, mastocytosis, and
specific forms of fibrotic wound repair under the control of the
cytokines interleukin-4 (IL-4), IL-5, and IL-13. More recently, the
ongoing refinement of our understanding of the type 2 immune
response and the recent description of new T-helper cell subsets,
force us to re-evaluate the guiding paradigm that would be infor-
mative to future studies of type 2 responses in the context of
helminth infection.
ROLE OF TYPE 2 IMMUNITY IN HELMINTH INFECTION
The role of type 2 immune responses in immunity against
helminths was initially revealed in studies that observed an inverse
correlation between levels of parasitemia and the expression of the
Th2 cell-derived cytokine IL-4 against the nematode Trichinella
spiralis (1, 2). These ideas have been further developed in experi-
mental models that show that signaling through IL-4Rα or the IL-4
signaling pathway STAT6 can play important roles in expulsion
of, or protection against, the nematodes Heligmosomoides poly-
gyrus (3), Nippostrongylus brasiliensis (4, 5), Trichuris muris (6),
the trematode Schistosoma mansoni (7), and the cestode Mesoces-
toides corti (8). Although the helminth infection-induced immune
effector response normally associated with IL-4 is the production
of IgE antibody, the Trichinella spiralis experimental infection
model is the only one to show a requirement for IgE in protec-
tion (9). It should also be noted that IL-4 mediated responses may
not always be protective as seen in the study showing STAT6−/−
mice have greater resistance to the cestode Tenia crassiceps (10).
IL-4 is not the only Th2 derived cytokine that can signal
through STAT6. The type 2 cytokine IL-13 has been shown to
play a key protective role in many helminth infections, partic-
ularly in the expulsion of parasites from the gut by mediating
goblet cell mucous production and smooth muscle cell contrac-
tion sometimes referred to as the “weep and sweep effect” (11).
Macrophages express IL-4Rα, and signaling via both IL-4 and IL-
13 can induce an alternately activated phenotype. Alternately acti-
vated macrophages produce factors that contribute to the repair
of tissues damaged by infection (12); they have also been shown
to be required for protective responses against some nematode
infections (13).
IL-5 is the third cytokine commonly associated with type 2
immune responses and the Th2 cell subset specifically. The main
function of this cytokine is the expansion of eosinophils from
the bone marrow (14) with overexpression of IL-5 leading to
decreased larvae numbers in primary infections of the nematodes
N. brasiliensis and Angiostrongylus cantonensis (15). Genetic dele-
tion or antibody neutralization of IL-5 or the IL-5 receptor α
(IL-5Rα) show a requirement for IL-5 and eosinophils in pro-
tective immunity against secondary infections of Strongyloides
stercoralis, Strongyloides venezuelensis, and Onchocerca lienalis
(16). Eosinophils and IL-5 have also been shown to play an
important role in vaccine-induced protection against Litosomoides
sigmodontis (17).
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Recent work has reported that the Th2 cell population is het-
erogeneous, containing some subpopulations of Th2 cells that
produce both IL-5 and IL-13 in the absence of concomitant IL-4
expression (18) and also some subpopulations of Th2 cells that are
IL-5+ or IL5−, while expressing IL-4 (19). Furthermore, a study
by Liang et al. demonstrated that production of IL-4 and IL-13 is
spatially separated with IL-13 being poorly expressed at low lev-
els by lymph node (LN) CD4+ T-cells but strongly expressed by
CD4+ T-cells found in the lung (20). These data, along with others,
showing that LN CD4+ T-cells expressing IL-4 in response to H.
polygyrus are primarily of the Tfh phenotype (T follicular helper)
(21), negates the view that IL-4 production is a sufficiently com-
prehensive marker for all the T-helper cell subsets activated during
the full expression of a type 2 immune response. It also raises the
issue of how we need to have a broader view of how CD4+ T-
helper cells should be defined and identified as contributors to
type 2 immunity.
THE PRIMING OF TYPE 2 T-CELLS IN HELMINTH INFECTION
The cellular and molecular mechanisms that lead to the priming
of type 2 T-cells during helminth infections are not well under-
stood. The IL-4 producing Th2 cell has received the most attention
in this regard, with early expression of Il4 used as a marker of
pre-commitment to a T-helper cell of the type 2 lineage. Although
IL-4 has been clearly demonstrated to promote overwhelming
polarization and differentiation of naïve CD4+ T-cells into Th2
in vitro (22), it has been difficult to identify the in vivo sources
of IL-4 that are able to affect the initial Th2 cell priming. More
importantly, in vivo studies indicate that Th2 cells can be effec-
tively primed even in the absence of IL-4- and STAT6-dependent
signaling (23–25), thus suggesting that signals other than IL-4
must be operating physiologically. The difficulty in identifying
such signals has led to the formulation of a number of models of
Th2 priming, which are briefly outlined in Figure 1 below, and
linked to available evidence in helminth infection models. Some
of this evidence has recently been reviewed (26) and thus is only
briefly discussed here.
Several lines of experimental evidence suggest that low-avidity
interactions between T-cells and antigen presenting cells (APC)
favor the development of Th2 immune responses (27) (Figure 1A).
Recent work in support of this possibility includes studies of
differential activation of T-cells using antigens of varying affini-
ties or concentrations (28, 29), different T-cell–APC ratios (30)
and, more recently, the reduced APC-naïve T-cell contact time
observed when T-cells are primed in vivo in conditions that
favor type 2 rather than type 1 differentiation (31). This model
of Th2 priming is strongly supported by many elegant studies
in well-defined experimental systems, often using homogeneous
T-cell populations expressing clonal T-cell receptor (TCR). How-
ever, models in which T-cell avidity is the sole driver of T-helper
FIGURE 1 | Proposed models ofTh2 differentiation induced by helminth
parasite antigens presented by DC. (A) Antigen taken up by DC is presented
to specific CD4+T-cells. Low-avidity interactions between CD4+T-cell and
DC result in the priming of Th2 cells, whereas high avidity interactions result
in the priming of Th1 or Th17 cells. (B) DC conditioned by parasite-induced
innate cytokines/cells, or directly conditioned by parasite products, acquire
the ability to prime Th2 responses. Th1 and/or Th17 responses are initiated by
DC conditioned by other innate signals. (C) A specific DC subset that is
uniquely able to take up parasite material is programed to prime Th2 immune
responses. The priming of other T-cell phenotypes requires other DC subsets.
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cell differentiation are difficult to reconcile with the observed
prevalence of specific phenotypes of immune response during
infections, when complex mixtures of antigens interact with T-
cells of a range of specificities such as those found in polyclonal
repertoires (32). The wide range of T-cell avidities involved in
such situations would predict that the resulting immune response
should include a mixture of T-cell phenotypes, but this is not
normally observed. It is possible that APC-derived signals, which
are differentially invoked by infectious agents such as intracellular
versus helminth parasites, might be involved in modulating the
strength of CD4+ T-cell activation, thereby resulting in preferen-
tial differentiation of a certain T-helper subset (33–36). At this
stage, the precise contribution of the avidity of APC-T-cell inter-
action to the induction of Th2 immune responses to helminth
parasites remains to be determined.
An alternative possibility is that Th2 cells might arise as a
“default,” in situations where the cytokines that normally direct
T-cells to differentiate into other phenotypes, such as Th1 or Th17,
are absent. Indeed, although parasites still require co-stimulation
in order to induce optimal Th2 priming (37, 38), they mostly
lack the microbes-associated molecular patterns (MAMPs) that are
key to strong APC activation, co-stimulatory molecule expression,
and IL-12 secretion (39–41). Alternatively, low-avidity APC-T-cell
interactions may fail to sustain the CD40L expression necessary
for optimal IL-12 production, as is observed with antigen-MHCII
ligands that engage the TCR with low avidity. While this scenario
could be consistent with the low-avidity model discussed above, it
is not consistent with experiments in IL-12 KO mice showing that
lack of this cytokine does not result in activation of Th2 responses
(42), or with many experiments showing that helminth products
suppress IL-12 production (43, 44) and instruct DC to initiate
Th2 immune responses (39, 45–49). Thus, the overall evidence in
support of this model remains limited.
Third, Th2 immune responses may be initiated by instructive
signals from the APC. These signals may be acquired by APC
through interactions with innate cell populations or mediators, or
may be constitutively expressed by specialized subsets of APC. The
nature of the APC that prime Th2 responses has been debated, with
mast cells (50), B-cells (51), and basophils (52) being suggested
as necessary, or even sufficient (53, 54), for in vivo Th2 induc-
tion in various models of immune responses including helminth
infections. However, later experiments in a S. mansoni model pro-
vided clear evidence that DC depletion was sufficient to ablate
Th2 induction, while basophil depletion had no effect (55). While
it may be reasonable to hypothesize that parasites with different
life cycles and target tissues may also involve different APC pop-
ulations, a key role of DC in priming Th2 responses is consistent
with a wealth of experiments in other types of T-cell responses,
and also with older experiments in B-cell-deficient mice (56, 57).
Altogether, the weight of experimental evidence appears to sup-
port DC as being the primary, and possibly the sole, initiator of
Th2 immune responses. This conclusion then leads to the ques-
tion: if DC is the principal APC population that primes Th2
responses, which properties enable them to do so, and how are
these properties acquired?
The interaction of DC with helminth products has been exten-
sively examined using DC generated in culture or, less frequently,
ex vivo spleen DC. These experiments were highly informative
and revealed, among other things, the limited upregulation of co-
stimulatory molecules on DC by helminth products (36, 40), the
role of CD40 (58, 59), OX40L (60), IL-4, and IL-12 (58), and
the effects of treatment with TLR ligands (61). However, these
results are limited by the fact that the cultured DC used in many
of those experiments may not have a physiological equivalent
in vivo, and splenic DC are not necessarily involved in the immune
response to the helminths of interest. These results must, therefore,
be extended and confirmed using in vivo models, which involve
relevant antigens, DC subsets, and routes of exposure.
As discussed above, helminths and their products can directly
or indirectly condition DC to prime Th2 responses (Figure 1B).
On the basis of current evidence, the best candidate molecule asso-
ciated with DC’s ability to program responding CD4+ T-cells to
a Th2 phenotype is OX40L (62, 63). Blocking OX40L on human
DC also suppresses their ability to prime IL-4-, IL-5-, and IL-13-
producing T-cells in vitro (64); however, studies using transfer of
mouse DC conditioned in vitro using SEA (S. mansoni Soluble
Egg Antigen) suggest that OX40L may also control T-cell expan-
sion in vivo (60). Expression of OX40L on DC can be induced
by the innate cytokines TSLP (Thymic Stromal Lymphopoietin),
IL-25, and IL-33 (64–66), which can be released by damaged
epithelia. In addition, some parasite products (39, 67) and CD40
signaling can also cause upregulation of OX40L expression (60,
67). Accordingly, innate cytokines were found to be dispensable
for IL-4 production after infection with several – but not all –
helminths, suggesting that parasite products may be able to bypass
the requirement for innate cytokines (49, 68, 69). Perhaps more
surprisingly, it was also found that OX40−/− mice can generate
IL-4 responses to N. brasiliensis (70), whereas IL-4 responses to H.
polygyrus are reduced but not ablated, suggesting a variable abil-
ity of helminth parasites to bypass or replace the requirement for
OX40L co-stimulation. Our experiments comparing Th2 immune
responses induced by various agents suggest that helminths may
not be unique in their ability to bypass the TSLP/OX40L axis, and
that HDM given intradermally can also induce TSLP-independent
Th2 responses (48, 71). These results may suggest that route of
exposure has a substantial effect on the involvement of innate
cytokines in the resulting Th2 immune response. While this pos-
sibility is plausible, it must be reconciled with information on
the innate environment in different tissues and, most importantly,
must be addressed and confirmed experimentally.
Finally, Th2 responses may require a specialized DC subset that
is specifically programed to carry out this function (Figure 1C).
The concept of a Th2-dedicated DC subset is not new (72), and
may fit with the DC heterogeneity that is gradually being revealed
in all tissues. In line with this notion, recent publications identified
a subset of skin DC, expressing the carbohydrate-binding molecule
CD301b (73) together with PD-L2 (Programed cell death ligand
2), which is preferentially able to take up “Th2-inducing” antigens.
These CD301b+ DC required IRF4 (interferon regulatory factor
4) for their development, and were necessary for the priming of IL-
4- and IL-13-producing T-cells in vivo and in vitro (74–76), but
not for IL-4-producing Tfh. Interestingly, while essential, puri-
fied CD301b+ DC were unable to prime Th2 responses in vitro
or upon transfer into recipient mice, suggesting that another cell
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population was also required (75). Similar to those reports, our
studies examining the DC populations involved in the immune
response to non-viable N. brasiliensis larvae given subcutaneously
(48) found that parasite material was preferentially taken up by
a migratory population of CD11b+ DC also expressing CD301b,
PD-L2, and IRF4. However, unlike the studies above, we were able
to show that transfer of total migratory DC from mice exposed
to non-viable N. brasiliensis larvae could prime Th2 responses in
naïve mice, and that this property was independent of the antigen
specificity of the responding T-cells. Importantly, we also found
that DC from untreated mice could induce T-cell expansion in vivo,
but not Th2 responses. Thus, our results suggest that exposure to
helminths and the attending innate signals are important factors in
conditioning DC for Th2 priming. As our experiments used trans-
fer of mixed populations of DC, we cannot conclude on whether
Th2 priming was the property of one specific DC population,
or whether it required the cooperation of several DC subsets. In
any case, the powerful Th2-inducing properties of helminth par-
asites are likely to provide a useful model in which to investigate
functional DC subsets in airway and intestinal tract, and their rela-
tionship to CD301b+ DC. The report that IRF4 expression by DC
is necessary for the priming of Th2 responses to inhaled allergens
(77) suggests that DC populations able to prime Th2 responses in
different tissues may share some common features. Whether these
observations also apply to the other CD4+ T-helper cell subsets
has yet to be determined.
NEW T-HELPER CELL SUBTYPES ASSOCIATED WITH
HELMINTH INFECTION
The development of new technologies, including multicolor flow
cytometry and the engineering of fate-mapping and cytokine
reporter mice, has lead to the discovery and definition of new
subsets of T-helper cells in the past 10 years, namely Th17, Th22,
Th9, Tfh and the recently suggested ThGM (T-helper producing
GM-CSF). The roles of these newly described subsets, especially
in the context of helminth infection, have not been fully eluci-
dated. Here, we review the findings to date in this area, and outline
the future questions that will be important to address. The role
of Tregs in helminthes infection has been extensively reviewed
(78–80) recently and so will not be discussed in this review.
Th9 CELL SUBSET IN HELMINTH INFECTION
IL-9 was originally associated with the Th2 immune response,
with reports that IL-9 expression by CD4+ T-cells was high in
Th2-pre-disposed, susceptible BALB/c mice infected with Leish-
mania major, and lower in resistant C57BL/6 (81). This view
was further confirmed in anti-helminth immunity a few years
later (21, 82, 83). However, recent work has shown that IL-9
and IL-4 are rarely produced by the same T-cells, thus sug-
gesting that IL-9-expressing cells represent a discrete T-helper
subset, termed Th9 (84, 85). However, both Th17 and iTregs
cells have also been shown to be able to produce detectable
amounts of IL-9, though not to the extent of Th9 cells. The
status of Th9 as a T-helper subset has been further strength-
ened by the discovery that IL-4 and TGF-β were permissive for
Th9 subset differentiation (84) with PU.1 defined as the nec-
essary transcription factor. It is important to note that even
if Th9 is now considered as a distinct subset, its proximity to
cells of the Th2 subset is re-enforced by both the demonstra-
tion that IL-4 is needed to differentiate Th0 cells into Th9, and
by the observation of inter-conversion of Th2 into Th9 in pres-
ence of TGF-β (84). More recently, however, IL-1 family members
have been shown to be able to trigger an IL-4-independent Th9
differentiation (86).
IL-9’s role in helminth infection has recently been suggested in
two consecutive studies showing that IL-9 transgenic mice infected
with either T. muris or T. spiralis had an increased Th2 response
and faster expulsion of the parasite from the intestine (82, 83). In
these studies, increased mast cell and eosinophil numbers corre-
lated with increased IL-9 levels, and were suggested as downstream
cellular effectors. However, further studies showed that mice vacci-
nated with IL-9-OVA complex recruited similar numbers of mast
cells and eosinophils to the gut of T. muris-infected mice, even
though the treatment inhibited expulsion of the parasite (87). No
other change to the type 2 response was noted. Conversely,vaccina-
tion with IL-9-OVA complex did facilitate expulsion of T. spiralis,
illustrating that despite the general association of type 2 immunity
with helminths, the effectiveness of each subtype is fine-tuned to
the parasitic species involved (88). In this regard IL-9 has been
shown to increase jejunal muscle contractility, and in IL-9-OVA
complex vaccinated mice infected with T. muris contractility of
the intestine was significantly decreased (88).
More recently, IL-9 has been shown to be produced by T-cells
during N. brasiliensis infection (89, 90) with adoptive transfer of
Th9 cells shown to be sufficient for mediating worm expulsion
(89). However, the modest differences in worm burden detected
between infected IL-9−/− and wild type mice, the high experimen-
tal variability, and the need for timing differences for expulsion to
be considered indicate that further work is needed to determine
the role of IL-9 in the context of immunity to reinfection (90).
In a Trichuris model, using CD4dnTGFbRII mice (which lack
Th9 cells) evidence suggested that Th9 cells are required for effi-
cient expulsion of the parasite (84). The susceptible phenotype
was associated with a decrease in mastocytosis and IL-9 expres-
sion in the mesenteric LN. However, the presence and frequencies
of IL-9 producing CD4+ T-cells in vivo was not assessed in this
study and the CD4dnTGFbRII mice had a decreased IL-4 response
but normal IL-13 response to Trichuris, indicating possible defects
other than the lack of IL-9, that could contribute to susceptibility.
Finally, IL-9 has a role in controlling fibrosis through upregulation
of prostaglandin E2 (PGE2), a well-known anti-fibrotic molecule
(91), and has been recently shown to be essential to mucosal
wound healing in an oxazolone-induced colitis model, through
the upregulation of claudin-2 in intestinal epithelial cells (92).
Th17 CELL IN HELMINTH INFECTION
Th17 was identified as a subset distinct from Th1 and Th2 differ-
entiation in 2005 (93), based on cellular production of IL-17 in
the absence of IFN-γ or IL-4. These cells are considered proin-
flammatory as they express high levels of their signature cytokine
IL-17, as well as IL-22, IL-6, and TGF-β, all under the control
of the master transcription factor RORγt. Combinations of IL-
23, TGF-β, IL-6, and IL-21 direct the differentiation of Th17 cells
from naïve CD4+ T-cells (94). Th17 cells exacerbate experimental
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autoimmune encephalomyelitis (EAE) (95) but also contribute to
protection against models of fungal infection (96).
The role of Th17 in helminth infection has principally been
studied in S. mansoni models, where it has been strongly asso-
ciated with infection-induced immunopathology. The pathologic
role of IL-17 in helminth infection was originally recognized by
its association with the development of hepatointestinal perioval
granulomas caused by S. mansoni infection. In these early stud-
ies, CD4+ T-cells were known to be required for the development
of the pathology (97, 98), and under the Th1:Th2 paradigm, the
role of IL-17 was interpreted as being part of the Th1 immune
response causing increased pathology versus a less destructive
Th2-dominant response (99).
Further, in an interesting study of mouse strain related suscep-
tibility to pathology (100), it was found that pathology was dimin-
ished in IL-12p40−/−mice but not IL-12p35−/− and that IL-17 but
not IFN-γ levels correlated with disease, indicated that pathology
was likely controlled by Th17 cells in an IL-23 dependent manner
(100). Further evidence for this was provided by genetic depletion
of IL-23 and disruption of IL-1β signaling leading to decreased
IL-17 levels and decreased pathology (101). Furthermore, CD4+
T-cells from TCR transgenic mice recognizing Schistosoma anti-
gen Sm-p40 expressed IL-17 when stimulated by DCs loaded with
Schistosome eggs (102). Antibody neutralization of TGF-β lead
to decreased plasma levels of IL-17 and a reduced worm burden,
although this may have also changed other parameters includ-
ing Treg populations (103). IL-17 from RORγt expressing Th17
cells was also associated with the severe pathology seen in natural
infection with Schistosoma japonicum with antibody neutraliza-
tion of IL-17 leading to diminished neutrophil infiltration in the
liver and reduced hepatic and pulmonary pathologies (104–106).
IL-17-associated pathology is also evident in human studies with
children infected with Schistosoma haematobium having a higher
circulating Th17:Treg cell ratio than those children infected but
pathology-free, mirroring the ratios seen in high-pathology CBA
mice compared to mild pathology C57Bl/6 (107). While studies
identifying T-cells producing IL-17 in Schistosoma infected tissues
show that most are CD4+ T-cells, the link to the expression of
the transcription factor RORγt has been rarely attempted, also
the downstream mechanisms of IL-17-associated immunopathol-
ogy remain largely unknown, with few studies indicating which
responding cellular components mediate granulomatous damage.
With respect to immune responses to other helminth phyla,
the role of Th17 is less clear. An association between pathol-
ogy and Th17 has been suggested in human filarial infection
with patients exhibiting lymphedema caused by lymphatic filar-
iasis having increased numbers of peripheral blood lymphocytes
producing IL-17 along with decreased Tregs number (108). The
presence of cytokines IL-1β, IL-23, and TGF-β have also been
shown to augment these filarial-specific Th17 responses (109).
Pulmonary hemorrhaging and neutrophilia caused by migration
through the lung by N. brasiliensis, a rodent hookworm, was also
shown to be dependent on IL-17 expression (110).
While the association of Th17 and IL-17 with pathology in
helminth infection is robust, there is limited evidence of a role
of Th17 in protection against helminths. One study, looking in
blood cultures from patients who received praziquantel to clear
S. haematobium infection demonstrated an association between
high levels of Th17-associated cytokines (IL-21 and IL-23) with
a decreased risk of re-infection (111). IL-17 expression has also
been linked to both mucosal damage and hyper-contractility of
the jejunum of T. spiralis-infected mice suggesting a role of Th17
in expulsion of the worms from the gut, but the study is highly
preliminary and no depletion of IL-17 was attempted (112). Echi-
nostoma caproni establishes a chronic infection in mice while rats
are able to expel the worms after 4 weeks post-infection. Intesti-
nal Th17-family cytokines IL-17, IL-23, and TGF-β were markedly
upregulated in rats but not in mice, suggesting Th17 activation may
be protective in this model (113). Conversely, an ovine model of
Teladorsagia circumcincta infection demonstrated increased Th17
cytokines correlating with susceptibility to infection (114). Over-
all, the role of IL-17 producing Th17 cells in helminth driven
immune responses is preliminary, and further work is needed.
Th22 CELL IN HELMINTH INFECTION
The cytokine IL-22 is normally associated with responses to
microbes and its production mainly attributed to Th17 cells in
both mice and human beings (115). However, a distinct subset
of human skin CD4+ T-cells has recently been shown to pro-
duce IL-22 but not IL-17 or IFN-g (116–118), and thus has been
given the term “Th22”. Th22 responses have been more widely
studied in human beings than in mice so far, with a broad range
of functional activities demonstrated, both proinflammatory and
anti-inflammatory. While IL-22 is mainly produced by immune
cells, the expression of its receptor IL-22R is mostly restricted
to non-hematopoietic cells, such as epithelial cells (119). Th22
cells arise from the stimulation of naive T-cells in the presence
of IL-6 and TNFα or presentation of antigen in the context of
plasmacytoid dendritic cells, and appears to be independent of
RORγt but dependent upon the aryl hydrocarbon receptor (AHR)
(116, 120, 121).
To date, only a few studies have attempted to address the role of
IL-22 in the context of helminth infection. IL-22 is upregulated in
the intestinal mucosa after infection by Trichuris trichuria or Neca-
tor americanus in human beings (122–124) and Th22 frequency
in PBMC is higher in filarial-infected patients than in healthy
controls (109). While helminth infection clearly induces IL-22,
so far no role for Th22 in either immune-mediated protection
or pathology has been proven. In fact, IL-22−/− mice infected
with S. mansoni did not present significantly modified immune
responses compared to wild type controls, neither did the absence
of IL-22 modify the establishment of the parasite or the develop-
ment of pathology (125). In filarial infection, Th22 frequency in
PBMC was higher in lymphedema-positive people than in asymp-
tomatic people, as was their frequency after antigen restimulation
with both adult and microfilarial stages of the parasite (109). As
reported in the above section, IL22 produced by Th17 cells plays a
role in gut expulsion of N. brasiliensis and T. muris (126).
Th22 has also been reported to be involved in skin repair
mechanisms and as such may be relevant to the pathology follow-
ing skin penetration by helminths. Furthermore, IL-22 is known
to have a role in the control of dysbiosis in the gut (127). As
helminths have co-evolved with both the host and its micro-
biome (128), in order to observe the role of Th22 in helminth
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infection, it may be required to study the tripartite interaction of
microbiome–macrobiome–host rather that the classical bipartite
helminth–host interaction.
Tfh CELL SUBSET IN HELMINTH INFECTION
In distinction to the other CD4+ T-helper cell subsets, Tfh cells
were not initially described based on cytokine production and
transcription factor expression patterns, but rather by the expres-
sion of the surface marker CXCR5+ denoting its localization to
the germinal center of human tonsils. Tfh have since been shown
to promote germinal center formation and class switching of B-
cells in mice and are further characterized by their expression
of the inducible co-stimulatory molecule (ICOS), the inhibitory
receptor programed cell death-1 (PD-1), and B and T lymphocyte
attenuator (BLTA) (129). Bcl6 has been identified as the master
transcription regulator for Tfh cells (130–132).
In the context of N. brasiliensis infection, Tfh cells have been
demonstrated to express IL-4 but not IL-13 (20). This study also
reports that these IL-4+ Tfh cells localize to the B-cells folli-
cle, and not to tissue sites such as the lungs. Interestingly, work
by Glatman Zaretsky et al. demonstrated that IL-4-expressing
CXCR5+ Tfh cells could develop from adoptively transferred
Th2 cells (CXCR5- and PD1-) in B-cell-sufficient hosts during
S. mansoni infection (133). Furthermore, IL-4 production by Tfh
cells is essential for proper B-cell expansion and activation, as
demonstrated by a reduction in B-cell activation in IL-4R−/−
mice (21).
The role of Tfh was studied in the context of S. japonicum
induced pathology model (134). In ICOSL−/− mice that are defi-
cient in Tfh cells, a diminution of the liver pathology is associated
with a decrease in Th1 and Tregs, whereas Th2 and Th17 are unaf-
fected. Furthermore, adoptive transfer of Tfh cells to ICOSL−/−
mice proved sufficient to re-establish pathology characterized by
the accumulation of cells in granulomas in the liver (134). Fur-
thermore, plasma cells have been shown to be present in the
granuloma induced by S. japonicum infection in both pig and
mice, and depletion of B-cells reduced pathology in this model
(135, 136).
In the context of non-helminth infections, Tfh cells have been
shown to produce IFN-γ and several studies suggest that Tfh
cell production of Th1-, Th2-, and Th17-associated cytokines
provides further evidence that they are potentially derived from
these lineages (129). Whether these different patterns of cytokine
expression reflect different subsets of Tfh cells, akin to those
observed in T-helper subsets and ILCs, is still unclear. The use
of Bcl6 reporter mice may help to distinguish Tfh cells from other
T-helper subsets and to provide an answer to this question, and
may allow the identification of other cytokine patterns in Tfh cells
that are induced in helminth infection in parallel with the other
T-helper subsets.
HYPOTHETICAL ThGM CELL SUBSET IN HELMINTH
INFECTION?
ThGM are the most recently proposed CD4+ T-helper subset
having been described in in vitro studies developing from naïve
CD4+ T-cells stimulated with anti-CD3 and anti-CD28, in the
absence of IL-4, IFN-γ, and IL-12 (137). It is important to
note that to our knowledge, this subset has not been described
in vivo so far and that its existence will have to be further
confirmed.
Putative ThGM cells produce high levels of GM-CSF, while
not producing Th1- or Th2-associated cytokines. The authors
further show that they do not express T-bet, GATA3, RorγT, or
Foxp3, thus supporting the idea that they indeed constitute a new
CD4+ T-helper subset (137). GM-CSF is a pluripotent cytokine,
which has been shown to induce T-cells proliferation and acti-
vate macrophages and neutrophils, among other cells, and the
absence of this cytokine has been shown to negatively impact the
differentiation of both Th1 and Th2 responses (138).
Contrasting roles have been shown for GM-CSF in helminth
infection settings. In N. brasiliensis infection, mice deficient in
GM-CSF show no reduction in worm burden in the lungs or gut
in both primary and secondary infection when compared to wild
type mice (139).
In Onchocerca volvulus infection, presumably immune individ-
uals (negative for the parasite, but living in endemic area) have a
mixed Th1/Th2 response to L3 and microfilariae antigen, contrary
to infected individuals that present only a strong Th2 response to
those antigens. In particular, GM-CSF, at that time considered as
a Th1 cytokine, was greatly enhanced in the putatively immune
individuals (140). Co-cultivating human PBMCs in vitro with
the Schistosoma antigen SmGST28 has been shown to be suffi-
cient to induce some granulomatous formations, and GM-CSF is
needed for this reaction (141), suggesting a role for this cytokine
in development of pathology.
FURTHER T-HELPER CELL DIVERSITY AND PLASTICITY IN
HELMINTH-INDUCED TYPE 2 IMMUNE RESPONSES
In the original Th1/Th2 paradigm, it was proposed that the
T-helper cell subsets were distinct and negatively regulated each
others’ activities, all underpinned by regulatory epigenetic methy-
lation signatures interacting at IFN-γ, IL4, Gata-3, and T-bet gene
loci (142, 143). However, this concept has to be revised in light of
the recent discoveries of additional functionally diverse T-helper
subsets including those with mixed Th1/Th2 signature cytokine
phenotypes and by the observation that certain T-helper subsets
can reverse their degree of polarization (144, 145).
Although it has been known for some time that double-positive
IFN-γ+IL-4+ T-cells can be detected in experimental models of
Th2 differentiation (146), when viewed in the context of the orig-
inal Th1/Th2 paradigm, they were considered to be Th0 cells that
were not yet committed to a polarized phenotype. However, sev-
eral recent publications clearly demonstrated that these Th1/Th2
hybrid cells are stable both in vitro and in vivo after infection with
either the trematode S. mansoni and the nematode H. polygyrus
helminth infections (146, 147). Furthermore, this Th1/Th2 hybrid
cells arise in a IL-18-dependent manner in S. mansoni infected
mice (148). Interestingly, adoptive transfer of Th1/Th2 hybrid
into Th1 or Th2 inflammatory models (LCMV and allergic airway
inflammation) showed in both cases a reduced pathology associ-
ated with the inflammation (147). At the molecular level, these
Th1/Th2 hybrid cells present with an intermediate expression of
Gata-3 and T-bet as compared to Th2 and Th1 cells, respectively,
due to an intermediate signature of methylation, for example,
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gata3 methylation was 36% in those cells, versus 60% in Th1 and
8% of Th2 (149).
Both T-bet and GATA3 can regulate each others expression
(150), and in a recent study, RORγt and Foxp3 were shown to
directly interact in a way that determines Th17 versus induced
Treg lineage (151, 152). Also, it has been shown that Tfh cells can
express both Gata3 or T-bet and that while Bcl6 decreases their rel-
ative expression it does not block it completely (153). Taking these
observations together, it would seem reasonable to speculate that it
is the ratio of transcription factors induced that may determine the
fate of any developing T-helper subset and that as a T-helper cell
differentiates there is available a broad contiguous range of gene
expression patterns for shaping its ultimate phenotype during an
immune response against a helminth (Figure 2A) (154).
The possibility of potential inter-conversions of different
T-helper subsets in the context of a helminth infection has recently
been studied (155). Both in vitro- and ex vivo-generated Th1 and
Th17 cells, adoptively transferred into mice later infected with
N. brasiliensis, were shown to convert into IL-4 producers while
losing their own signature cytokine expression. Also, both the
iTregs and the nTregs were found to be stable in vivo in this study,
with only low number of cells converting to express IL-4 (155). It
is interesting to note that the in vitro-generated Th1 and Th17 cells
showed a lower propensity to convert after transfer, suggesting that
in vitro culture has a strong impact on the degree of T-helper cell
plasticity that can be observed and perhaps explaining why the
initial in vitro investigations into T-helper subset differentiation
found subsets were highly stable and thus terminally differentiated.
Based on observations of the diversity and apparent plastic-
ity of T-helper subsets phenotypes that can be detected now and
on dynamic systems theory, we propose a landscape representa-
tion of the possibility of inter-conversions and intermediary states
for T-helper cell subsets developing in the context of a helminth-
induced immune response (Figures 2B,C). We have represented
the dynamic of T-cells’ fates on a quasi-potential landscape in
which the different subsets constitute stable states, also called
attractors. In this view, the subsets are in “valley” or “flat” areas. To
transit from one stable state to another, the system needs to be per-
turbed, for example by an infection that would push cells toward
certain attractors or away from others. Unstable states are usually
represented as “hills.” The Th1/Th2 hybrid state is stable enough,
but less that the more terminally differentiated Th1 and Th2, and
is thus represented by a well with less depth than Th1 or Th2.
Using such a “continuum of T-helper cell phenotypes” para-
digm, it would be predicted that in host tissues responding to
helminths there would be a gradient of activated and differenti-
ated T-helper cell subsets with the most fully differentiated being
stable and having lost much of their plasticity. Such terminally dif-
ferentiated helper T-cells, maybe such as Th2, probably represent a
small proportion of the pool of memory effector T-cells that main-
tain the helminth antigen specificity and the appropriate cytokine
profile.
FIGURE 2 | Dynamic ofT helper differentiation. (A)The dynamic of T
helper differentiation can be visualized as a “potential landscape” in which
each T helper subset represent a stable position or “valley” and the
transition from one subset to another, would be a “hill”, difficult to pass.
Initially, the transition state between T helper subsets was considered as
instable, and thus not observable in vivo. However, Th1/Th2 hybrid
population has recently been reported to be stable after helminth
infection. As this hybrid state is less abundant than Th1 or Th2, one could
presume that the hybrid population is less stable that the Th1 or Th2
subsets, thus represented as a less deep well. (B)This transition between
subsets can be further defined by the ration of transcription factor
participating in the fate determination of each subset. For example, the
Th1/Th2 population has been shown to present intermediary level of
gata-3 and T-bet expression as compared respectively to Th2 and Th1.
Through similar transcriptomic approach, generalised on all the T helper
subsets, it would thus be possible to define a ration of transcription
factors necessary to enable the switch from one subset to another.
(C)The plasticity of the T helper subsets is represented in a conceptual 3D
potential landscape and illustrate that the diverse repertoire of T helper
cell subsets, and its important plasticity, enable the host to have an array
of fine-tuned adaptive responses to both control the parasite development
and avoid and repair pathology caused by the worm migration.
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TYPE 2 IMMUNE RESPONSES TO HELMINTH INFECTION ARE
A COMPROMISE BETWEEN PROTECTION, SUSCEPTIBILITY,
TISSUE REPAIR, AND PATHOLOGY
The original paradigm explaining resistance or susceptibility to
helminths was described as a simple balance between Th1 (the
susceptible, pathologic response), and Th2 (the response confer-
ring parasite killing and elimination). However, this paradigm did
not satisfactorily explain why so many parasites are able to establish
themselves in hosts for extended periods of time (sometimes for
decades) without causing any major clinical symptoms, nor why, in
endemic environments, hosts are continually being reinfected with
no apparent sign of disease. The hypothesis that the immune sys-
tem would ignore the parasite infection was unconvincing,begging
the question of whether these parasites themselves actively down-
regulate the host immune response and control pathology. Con-
sequently, much research on helminth infection has focused on
understanding how the parasite could regulate immune responses
and teasing apart what is the physiological purpose of the type 2
effector responses in terms of benefit to host survival.
With the emergence of data showing that helminths and their
products could be used to prevent/cure both allergic and autoim-
mune (156), our understanding of the immune response against
helminth has changed to take into account the regulatory mecha-
nisms induced by the parasites. From this emerged a new concept,
the “modified Th2,” characterized by a decrease IL-5 and IL-13
expression and an increase of anti-inflammatory cytokines, such
as TGF-b and IL-10. Other cells types, such as regulatory myeloid
cells or regulatory B-cells have been shown to be involved in the
downregulation induced by helminth.
The Th2 immune response has also been shown to be part
of a wound repair response, with the ability to block a runaway
pathology. This is clearly illustrated in IL-4−/− mice infected with
S. mansoni that die from excess pathology, even if their worm bur-
den was similar to the wild type control mice (157). Th2 immune
response has been considered as having evolved to cope both with
helminth infection and with damage repair mechanisms, necessary
to the survival of the host against those multicellular metazoan
parasite migrating through tissue (12, 158). New research has
shown that IL-9 has roles in controlling fibrosis and wound repair
(91, 92), and that IL-22 from Th22 and Th17 cells promotes heal-
ing by increasing proliferation and survival of keratinocytes and
intestinal epithelial cells (118, 159, 160). These data indicate that
Th2 may not be the only T-helper subset contributing to the repair
of helminth-induced tissue damage.
Furthermore, ES-62, a secretory product of the filarial nema-
tode Acanthocheilonema viteae, may play with the balance of the
different T-helper subsets in order to diminish the protective
immune response (161). In a murine model of OVA-induced
allergic airways inflammation, ES-62 decreased Th2 responses, as
shown by a reduced level of IL-4 in the broncho-alveolar fluid,
decrease eosinophils recruitment, and IgE. In parallel, the Th1
immune response is exacerbated, and neutralization of IFN-γ ini-
tiated the allergic inflammation blocked by ES-62 treatment. Th17
was also suppressed in this model, and that this suppression is
responsible for the increase of the Th1 response. Importantly, ES-
62 in this model did not induce an increase of Treg population, thus
suggesting that the immunomodulatory effect of the molecule is
to modify the balance of CD4+ T-helper subsets. This is the key
data to understanding that the regulation of immune responses
is not solely controlled by Tregs, but the different CD4+ T-cells
subsets themselves antagonize one another.
Considering the fact that all the currently recognized sta-
ble CD4+ T-helper phenotypes have been observed during
helminth infections, and that these different subsets contribute
variously to either protection, wound healing, susceptibility, or
immunopathology, we have designed a new model that condenses
what is known about the direct contributions of the subsets and
their cross-regulation of each other. This model demonstrates our
better understanding of the balanced immune responses during
helminth infection Figure 3.
The early opposition of Th1 and Th2 is still clearly visible
as a driving force for the trade-off between host and helminth
survival. Th2 and Th9 segregate together to confer resistance,
as they share a common activation pathway through IL-4. They
are opposed to Th1 and Th17 in regard to pathology and to
Th1 and Tregs in regard to susceptibility and chronicity. This
model emphasizes that what may be best for the host is a
compromise between elimination of the parasite versus contain-
ment and also the need for rapid repair of damaged tissue and
avoidance of self destructive pathology. This all-encompassing
FIGURE 3 | Evolution of the view onT helper involvement in helminth
infection. By taking into account all the other T helper subset known to
date, it is proposed that an immune response against on helminth can be
summarized as a 2D map defined by an axis of susceptibility/protection and
an axis of pathology/damage control. For an optimal response against a
parasite, the host would thus mount a Th2/Th9 response with a low Tregs
response and almost not existing Th1, Th17 response. The Th2 arm of the
immune response protects against helminth by expanding ILCs,
eosinophils and basophils all involved in parasite expulsion or by activating
macrophages in AAM, playing a role in granuloma formation. Th9 rather
protects by increasing goblet cells hyperplasia and muscle contractility in
the gut. Th17 induced pathology is mainly mediated by neutrophils and
inflammatory macrophages. In contrary, Tregs induced development of
regulatory macrophages, which control pathology.
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view of an immune response gives a better understanding of
the host issues at stake and gives a context for further inves-
tigations to investigate roles for each of the T-helper subsets.
Furthermore, the consideration of a multipartite balance, rather
than a one in one balance, would be useful to the design of
therapy against helminths (i.e., by developing adjuvant to vac-
cine that could determine the right balance of Th susbsets to
obtain sterilizing immunity, and define the timing to admin-
ister such treatment), and to understand how helminth infec-
tion or their product could use a therapy against inflammatory
and autoimmune disease, caused by the deregulation of different
T-helper subsets.
DISCUSSION/REMARKS
The new challenge to the investigation of type 2 immune responses
is to determine how many subsets of T-helper cells exist and what
mechanisms control the level and degree of plasticity that occurs
between T-helper cell subtypes. The question arises as to what
would be the benefit to the host to have such complexity and myr-
iad of genetic events underpinning this plasticity of the T-helper
cell response. We would argue that the benefit to the host in being
able to generate so many T-helper subsets is to have the diversity
of options for dealing with the myriad of parasitic forms, invasive
routes, and environments that have an endless supply of parasites
that invade by physical means. In effect, the diversity and plasticity
of the repertoire of functional T-helper cell subsets enable the host
to have an array of adaptive responses. While the response might
not kill the worm, it will enable the host to repair the more seri-
ous damage caused by the migrating parasite, and avoid the fatal
consequences of debilitating pathology.
We wish to point out that in order to study the type 2 immune
response elicited by helminths, i.e., define the role of the various
old and new discrete CD4+ T-cell subsets, both techniques and
approaches will have to evolve. For example, as plasticity between
different T-helper subsets become increasingly evident, it maybe
of interest to define a subset by both the cytokine production/non-
production patterns, as well as by the ratio of transcription fac-
tors they express. For this matter, engineered reporter mice for
particular cytokines and even combinations of cytokines may
help in in vivo studies but may not reflect the native mRNA or
protein. New bioinformatics approaches, such as studies of the
transittability (162) (that defines the lower number of molecule
switch to go from one fate of differentiation to another one based
on a network of molecules involved in shaping the cell fate), could
provide in the near future a list of more appropriate marker nec-
essary to define one particular T-helper subset. Moreover, due to
the plasticity of the T-cells, we think it is important to remember
that immune studies look at dynamic events, and as such looking
at a precise time point in the model, may give a wrong picture of
the actual mechanism, for example a subset “in transition,” may be
missed because of the lack of markers used for describing it, or the
relative rarity compared with the currently defined stable subsets.
Hopefully, advances in single cell analysis (Fluidigm), sequenc-
ing, multiplex quantification of transcripts (such as nCounter,
Nanostring that can detect up to 800 genes), advanced multicolor
flow cytometry (such as panels up to 20 colors), the emergence
of mass cytometry (such as CyTOF that allows multi-detection of
up to 34 parameters to date, but could potentially go up to 100),
coupled with bioinformatic approaches may offer the new tools
necessary for studying the dynamics of T-helper differentiation in
the context of helminth infection.
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